Condition
Squamous Cell Carcinoma of the Hypopharynx clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Squamous Cell Carcinoma of the Hypopharynx clinical trials that are recruiting, at sites in 2 countries (most in Germany (3), Netherlands (1)). By phase: Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Squamous Cell Carcinoma of the Hypopharynx clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Immune biomarker testing in cisplatin-ineligible head and neck squamous cell cancer patients treated with chemoradiation and docetaxel | — | Erlangen, Bavaria | Recruiting | Apr 27, 2025 |
| Platform for studying biomarkers and treatments in head and neck cancer | — | Essen and 1 other locations | Recruiting | Apr 24, 2024 |
| Reducing radiation therapy for head and neck cancer patients | Phase 2/3 | Erlangen, Bavaria | Recruiting | Sep 11, 2023 |
| Fluorescence-guided surgery to help remove laryngeal and hypopharyngeal cancers | Phase 2 | Rotterdam, South Holland and 1 other locations | Recruiting | Mar 2, 2023 |
All recruiting trials (4)
-
Immune biomarker testing in cisplatin-ineligible head and neck squamous cell cancer patients treated with chemoradiation and docetaxel
This project will test whether immune markers from tumor tissue, blood, saliva and stool can help predict outcomes and show increased tumor immune activity in people with oropharynx, hypopharynx, larynx or oral cavity squamous cell cancer who can't take cisplatin and are receiving chemoradiation with docetaxel.
-
Platform for studying biomarkers and treatments in head and neck cancer
This study is trying to gather information on how well different treatments work for people with advanced head and neck cancer to help improve future care.
-
Reducing radiation therapy for head and neck cancer patients
This study is testing if cutting back on radiation for head and neck cancer patients can help reduce side effects while still keeping the cancer under control.
-
Fluorescence-guided surgery to help remove laryngeal and hypopharyngeal cancers
This trial tests a fluorescent imaging agent to help see cancer tissue during laryngeal and hypopharyngeal cancer surgery in adults.
Related topics
Quick answers
How many Squamous Cell Carcinoma of the Hypopharynx clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Germany (3 trials), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.